Towards Healthcare
Biotechnology CMO and CDMO Market to Rise at 11.54% CAGR till 2034

Biotechnology CMO and CDMO Market Evolution and Opportunities

Market insights predict the global biotechnology CMO and CDMO industry will increase from USD 67.25 billion in 2024 to USD 199.67 billion by 2034, achieving a CAGR of 11.54%. The biotechnology CMO and CDMO market is growing because these services help to save pharmaceutical and biotechnology organizations money for manufacturing novel drugs. North America is the dominant market due to the presence of a well-established and sophisticated biopharmaceutical ecosystem.

Content

  • Insight Code: 6253
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The biotechnology CMO and CDMO market stands at USD 74.01 billion in 2025 and is expected to reach USD 199.67 billion by 2034, growing at a CAGR of 11.54% from 2024 to 2034.

North America is currently leading the biotechnology CMO and CDMO market share 42% due to the presence of major biotech and pharmaceutical organizations and a skilled workforce.

The biotechnology CMO and CDMO market includes six segments: by service type, by product type, by scale of operation, by technology platform, by end-user, and by region.

A Contract Manufacturing Organization (CMO) is a company that provides manufacturing services to pharmaceutical and biotechnology firms on a contract basis.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions